Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333122 · ClinicalTrials.gov registry record
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
A clinical trial of Breast Cancer Female, sponsored by Henry Ford Health System.
- Active
- Registry status
- 575
- Enrollment target
- 1
- Study location
NCT03333122: Active study of Breast Cancer Female, sponsored by Henry Ford Health System.
NCT03333122 is a study of Breast Cancer Female that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 575 participants, below the 680-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03333122, a study of Breast Cancer Female, is active but no longer recruiting, sponsored by Henry Ford Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 575 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of breast cancer on their expected outcomes and results. The hypothesis is that using prospectively obtained data to guide surgical decision-making and optimize access to surgical procedures would improve the treatment of patients and would most likely positively impact the health-related quality of life in patients.
Primary Outcome
The BREAST-Q survey is used to determine differences in health-related of life between treatment groups.
Conditions Studied
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 575 participants |
| Start Date | 2017-10-31 |
| Est. Completion | 2030-01 |
What the registry record for NCT03333122 still lists
NCT03333122 is an observational study that tracks outcomes without assigning an intervention. The registered 575 participants enrollment target is mid-sized for trials with a published cap, below the 680-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 0 interventions.
NCT03333122 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03333122 about?
NCT03333122 is a clinical study titled "Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes". The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of...
What is the current status of trial NCT03333122?
This trial is currently active not recruiting. The enrollment target is 575 participants. The study started on 2017-10-31. Estimated completion is 2030-01.
What conditions does trial NCT03333122 study?
This clinical trial studies the following conditions: Breast Cancer Female.
Who is sponsoring clinical trial NCT03333122?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03333122 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03333122's enrollment target sits among peer trials
575 7th of 46 higher than 40 of 46 other Breast Cancer Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06583148 · 575 participants · NA
A Smoke-Free Home Intervention in Tribal Communities
- NCT06883175 · 575 participants · NA
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI